2 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: CALADRIUS BIOSCIENCES, INC.
−Removed: August 4, 2022 By:
−Removed: President and Chief Executive Officer
+Added: LISATA THERAPEUTICS, INC.
+Added: November 10, 2022 By:
+Added: Chief Executive Officer
(Principal Executive Officer, Principal Financial Officer
and Principal Accounting Officer)
−Removed: CALADRIUS BIOSCIENCES, INC.
+Added: LISATA THERAPEUTICS, INC.
Exhibit Index
11 unchanged sentences
(filed as Exhibit 2.4 to the Company's Current Report on Form 8-K, filed with the SEC on April 27, 2022).
+Added: Certificate of Amendment (Reverse Stock Split) to the Amended and Restated Certificate of Incorporation, dated September 14, 2022 (filed as Exhibit 3.1 to the Company's Current Report on Form 8-K, filed with the SEC on September 15, 2022).
+Added: Certificate of Amendment (Name Change) to the Amended and Restated Certificate of Incorporation, dated September 15, 2022 (filed as Exhibit 3.2 of the Company's Current Report on Form 8-K, filed with the SEC on September 15, 2022).
Series D Preferred Stock Purchase Agreement, dated April 26, 2022, among Caladrius Biosciences, Inc.
4 unchanged sentences
(filed as Exhibit 10.2 to the Company's Current Report on Form 8-K, filed with the SEC on April 27, 2022).
+Added: # Employment Agreement, dated as of September 15, 2022, by and between the Company and David Slack (filed as Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the SEC on September 15, 2022).
+Added: # Form of Indemnification Agreement between the Company and each of its directors and officers (filed as Exhibit 10.2 to the Company's Current Report on Form 8-K, filed with the SEC on September 15, 2022).
+Added: # Cend 2016 Equity Incentive Plan, including all amendments thereto (filed as Exhibit 99.1 to the Company's Registration Statement on Form S-8, filed with the SEC on October 17, 2022).
* Certification of Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
11 unchanged sentences
** Furnished herewith.
+Added: # Management contract or compensatory plans or arrangements.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.